Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 4199  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
Read this article


    Article Cited by others


Repaglinide: a short acting insulin secretagogue for postprandial hyperglycaemia.

Ambavane V, Patil R, Ainapure S S

Year : 2002| Volume: 48| Issue : 3 | Page no: 246-8

   This article has been cited by
1 A validated chiral LC method for the enantiomeric separation of repaglinide on amylose based stationary phase
Rane VP, Shinde DB
CHROMATOGRAPHIA. 2007; 66 (7-8): 583-587
[Pubmed]  [Google Scholar]
2 Clinical presentation and treatment of type 2 diabetes in children
Pinhas-Hamiel, O., Zeitler, P.
Pediatric Diabetes. 2007; 8((SUPPL 9)): 16-27
[Pubmed]  [Google Scholar]
3 Type 2 diabetes in children and adolescents: Treatment
Zeitler, P.
Obesity Management. 2007; 3(5): 216-221
[Pubmed]  [Google Scholar]
4 Kir6.2-dependent high-affinity repaglinide binding to beta-cell K-ATP channels
Hansen AMK, Hansen JB, Carr RD, et al.
[Pubmed]  [Google Scholar]
5 Advances in epidemiology and treatment of type 2 diabetes in children
Pinhas-Hamiel, O., Zeitler, P.
Advances in Pediatrics. 2005; 52: 223-259
[Pubmed]  [Google Scholar]
6 Repaglinide is more efficient than glimepiride on insulin secretion and post-prandial glucose excursions in patients with type 2 diabetes. A short term study
Rizzo MR, Barbieri M, Grella R, Passariello N, Barone M, Paolisso G
Diabetes & Metabolism. 2004; 30(1): 81-89
[Pubmed]  [Google Scholar]


Online since 12th February '04
2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow